NYSE:SKY

Skyline Champion (SKY) Delivers Strong Financials, Beats Estimates

Font: Financial Modeling Prep  • May 26, 2026

Market Chart

Skyline Champion Corporation (NYSE:SKY) Delivers Impressive Financial Results Amidst Strong Housing Demand

  • Skyline Champion Corporation (NYSE:SKY) surpassed analyst estimates for both earnings per share and revenue, demonstrating strong financial performance.
  • As a leading manufactured and modular home builder, the company capitalizes on high traditional home prices, expanding its market reach and selling a record number of homes.
  • Skyline Champion Corporation exhibits robust financial health, characterized by a low Debt-to-Equity ratio of 0.01 and a strong current ratio of 2.48.

Skyline Champion Corporation (NYSE:SKY) is a large producer of manufactured and modular homes in North America. The company offers affordable housing options, which serve as an alternative for buyers as traditional housing market prices remain high, often near $500,000.

On May 26, 2026, Skyline Champion Corporation reports quarterly earnings of $0.68 per share, which beats the analyst consensus estimate of $0.63. As highlighted by Zacks, this represents a 7.94% earnings surprise. This is also an increase from the $0.65 per share reported in the same quarter a year ago.

The company's revenue also surpasses expectations, coming in at $621.28 million against an estimated $608.87 million. This marks a 4.6% increase in net sales from the prior-year period. This is the fourth consecutive quarter that Skyline Champion Corporation has surpassed consensus earnings per share estimates.

This performance is supported by strong orders and a deal with Homes Direct to expand its retail footprint in the western United States. During its fiscal year, the company sold a record 26,622 homes, showing strong demand for its products amid a softer industry backdrop.

Skyline Champion Corporation has a Price-to-Earnings (P/E) ratio of 19.74. The company shows a strong ability to cover its short-term debts with a current ratio of 2.48. Its very low Debt-to-Equity ratio of 0.01 indicates that the company relies very little on borrowing to finance its operations, highlighting its robust financial health.

Market Overview
BRTX
BioRestorative Therapies, Inc.
$0.39
58.05%
SOXS
Direxion Daily Semiconductor Bear 3X ETF
$6.63
5.41%
AIM
AIM ImmunoTech Inc.
$0.42
80.28%
SNGX
Soligenix, Inc.
$0.92
79.34%
TZA
Direxion Daily Small Cap Bear 3X ETF
$4.31
0.00%
ASTC
Astrotech Corporation
$17.30
600.20%
HOTH
Hoth Therapeutics, Inc.
$1.15
62.43%
NVDA
NVIDIA Corporation
$212.85
-0.94%
WOK
WORK Medical Technology Group Ltd.
$0.10
-7.21%
BITO
ProShares - Bitcoin ETF
$10.20
-1.69%